An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions

Background: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions....

Full description

Bibliographic Details
Main Authors: Christopher J. Carr, Jonathan Scoville, James Ruble, Chad Condie, Gary Davis, Candace L. Floyd, Logan Kelly, Ken Monson, Ethan Reichert, Buse Sarigul, Gregory W. J. Hawryluk
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Neurology
Subjects:
pH
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.667842/full
id doaj-41e3d09a6fc647f88d4bd0d304229f4e
record_format Article
spelling doaj-41e3d09a6fc647f88d4bd0d304229f4e2021-05-17T04:42:36ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-05-011210.3389/fneur.2021.667842667842An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline SolutionsChristopher J. Carr0Jonathan Scoville1James Ruble2Chad Condie3Gary Davis4Candace L. Floyd5Logan Kelly6Ken Monson7Ethan Reichert8Buse Sarigul9Gregory W. J. Hawryluk10Gregory W. J. Hawryluk11Department of Neurosurgery, Tulane University/Ochsner Clinic Foundation, New Orleans, LA, United StatesDepartment of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Pharmacotherapy, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Pharmacotherapy, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Pharmacotherapy, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Pharmacotherapy, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Pharmacotherapy, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT, United StatesDepartment of Neurosurgery, Okmeydani Education Hospital, Istanbul, TurkeySection of Neurosurgery, Department of Surgery, University of Manitoba, Health Sciences Centre, Winnipeg, MB, CanadaBrain Trauma Foundation, Palo Alto, CA, United StatesBackground: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions.Methods: We measured pH and concentration in 37 commonly-used hyperosmolar solutions, including 20 and 25% mannitol and 3, 5, 14.6, and 23.4% hypertonic saline. pH was determined digitally and with litmus paper. Concentration was determined by freezing point and vapor pressure osmometry. Salinity/specific gravity was measured with portable refractometry. Particulate matter was analyzed with filtration and light microscopy and with dynamic light scattering nephelometry.Results: pH of all solutions was below physiological range (measured range 4.13–6.80); there was no correlation between pH and solution concentration (R2 = 0.005, p = 0.60). Mannitol (mean 5.65, sd 0.94) was less acidic than hypertonic saline (5.16, 0.60). 14/59 (24%) pH measurements and 85/111 concentration measurements were outside manufacturer standards. All 36/36 mannitol concentration measurements were outside standards vs. 48/72 (67%) hypertonic saline (p < 0.0001). All solutions examined on light microscopy contained crystalline and/or non-crystalline particulate matter up to several hundred microns in diameter. From nephelometry, particulate matter was detected in 20/22 (91%) solutions.Conclusion: We present a novel characterization of mannitol and hypertonic saline. Further research should be undertaken, including research examining development of acidosis following hyperosmolar therapy, the relevance of our findings for dose-response, and the clinical relevance of particulate matter in solution.https://www.frontiersin.org/articles/10.3389/fneur.2021.667842/fullhyperosmolar therapyauditacid-base imbalancepHhypertonic salineintracranial hypertension
collection DOAJ
language English
format Article
sources DOAJ
author Christopher J. Carr
Jonathan Scoville
James Ruble
Chad Condie
Gary Davis
Candace L. Floyd
Logan Kelly
Ken Monson
Ethan Reichert
Buse Sarigul
Gregory W. J. Hawryluk
Gregory W. J. Hawryluk
spellingShingle Christopher J. Carr
Jonathan Scoville
James Ruble
Chad Condie
Gary Davis
Candace L. Floyd
Logan Kelly
Ken Monson
Ethan Reichert
Buse Sarigul
Gregory W. J. Hawryluk
Gregory W. J. Hawryluk
An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
Frontiers in Neurology
hyperosmolar therapy
audit
acid-base imbalance
pH
hypertonic saline
intracranial hypertension
author_facet Christopher J. Carr
Jonathan Scoville
James Ruble
Chad Condie
Gary Davis
Candace L. Floyd
Logan Kelly
Ken Monson
Ethan Reichert
Buse Sarigul
Gregory W. J. Hawryluk
Gregory W. J. Hawryluk
author_sort Christopher J. Carr
title An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_short An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_full An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_fullStr An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_full_unstemmed An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions
title_sort audit and comparison of ph, measured concentration, and particulate matter in mannitol and hypertonic saline solutions
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-05-01
description Background: The preferred hyperosmolar therapy remains controversial. Differences in physical properties such as pH and osmolality may be important considerations in hyperosmolar agent selection. We aimed to characterize important physical properties of commercially available hyperosmolar solutions.Methods: We measured pH and concentration in 37 commonly-used hyperosmolar solutions, including 20 and 25% mannitol and 3, 5, 14.6, and 23.4% hypertonic saline. pH was determined digitally and with litmus paper. Concentration was determined by freezing point and vapor pressure osmometry. Salinity/specific gravity was measured with portable refractometry. Particulate matter was analyzed with filtration and light microscopy and with dynamic light scattering nephelometry.Results: pH of all solutions was below physiological range (measured range 4.13–6.80); there was no correlation between pH and solution concentration (R2 = 0.005, p = 0.60). Mannitol (mean 5.65, sd 0.94) was less acidic than hypertonic saline (5.16, 0.60). 14/59 (24%) pH measurements and 85/111 concentration measurements were outside manufacturer standards. All 36/36 mannitol concentration measurements were outside standards vs. 48/72 (67%) hypertonic saline (p < 0.0001). All solutions examined on light microscopy contained crystalline and/or non-crystalline particulate matter up to several hundred microns in diameter. From nephelometry, particulate matter was detected in 20/22 (91%) solutions.Conclusion: We present a novel characterization of mannitol and hypertonic saline. Further research should be undertaken, including research examining development of acidosis following hyperosmolar therapy, the relevance of our findings for dose-response, and the clinical relevance of particulate matter in solution.
topic hyperosmolar therapy
audit
acid-base imbalance
pH
hypertonic saline
intracranial hypertension
url https://www.frontiersin.org/articles/10.3389/fneur.2021.667842/full
work_keys_str_mv AT christopherjcarr anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT jonathanscoville anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT jamesruble anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT chadcondie anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT garydavis anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT candacelfloyd anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT logankelly anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT kenmonson anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT ethanreichert anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT busesarigul anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT gregorywjhawryluk anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT gregorywjhawryluk anauditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT christopherjcarr auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT jonathanscoville auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT jamesruble auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT chadcondie auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT garydavis auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT candacelfloyd auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT logankelly auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT kenmonson auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT ethanreichert auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT busesarigul auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT gregorywjhawryluk auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
AT gregorywjhawryluk auditandcomparisonofphmeasuredconcentrationandparticulatematterinmannitolandhypertonicsalinesolutions
_version_ 1721438699096375296